63207-02-3

Basic information

• Product Name: ethyl 4-decylpiperazine-1-carboxylate
• Synonyms: 1-piperazinecarboxylic acid, 4-decyl-, ethyl ester; Ethyl 4-decylpiperazine-1-carboxylate
• CAS NO: 63207-02-3
• Molecular Formula: C₁₇H₃₄N₂O₂
• Molecular Weight: 298.4641
• Mol File: 63207-02-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 382°C at 760 mmHg
• Flash Point: 184.8°C
• Density: 0.955g/cm³
• Vapor Pressure: 4.87E-06mmHg at 25°C
• Refractive Index: 1.472
• CAS DataBase Reference: ethyl 4-decylpiperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 4-decylpiperazine-1-carboxylate(63207-02-3)
• EPA Substance Registry System: ethyl 4-decylpiperazine-1-carboxylate(63207-02-3)

Safety Data

• Hazardous Substances Data: 63207-02-3(Hazardous Substances Data)

Upstream product

• 41233-29-8 methanesulfonic acid decyl ester 
• 120-43-4 4-ethoxycarbonylpiperazine 
• 584-08-7 potassium carbonate 
• 112-29-8 1-bromo dodecane 

Downstream Products

• 63207-03-4 1-decylpiperazine 

Relevant articles and documents

2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use

The present invention provides substituted dibenzoxazepine and dibenzthiazepine compounds of Formula I: STR1 which are useful as analgesic agents for the treatment of pain, and for prostaglandin-E2 mediated diseases, pharmaceutical compositions comprising a therapeutically-effective amount of a compound of Formula I in combination with a pharmaceutically-acceptable carrier, a method for eliminating or ameliorating pain in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal, and a method for treating prostaglandin-E2 mediated diseases in an animal comprising administering a therapeutically-effective amount of a compound of Formula I to the animal.

3,4-Bis(4-substituted piperazinyl)-3-cyclobutene-1,2-diones and related compounds

3,4-bis(4-substituted piperazinyl)-3-cyclobutene-1,2-diones and related compounds having antiviral activity are described herein. The subject compounds can be prepared by reacting 3,4-dimethoxy-3-cyclobutene-1,2-dione with the appropriate substituted piperazine.